Different routes of progesterone administration for sustaining implantation in in vitro fertilisation patients: impact on pregnancy and live birth rates

Not Applicable

Completed

• Conditions: uteal phase supplementation in assisted reproduction; Pregnancy and Childbirth

• Registration Number: ISRCTN52148405
• Lead Sponsor: One Day Medical Center srl

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-12-23
• Study Start: 2023-08-15
• Last Update Posted: 28 August 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 620

Inclusion Criteria

1. Infertility attributable to tubal factors, moderate endometriosis, male factor, or idiopathic infertility
2. Serum hormonal profile within the normal range (AMH >1 ng/ml)
3. Regular menstrual cycles
4. The presence of a normal uterine cavity
5. Body mass index (BMI) of 20–26 kg/m²

Exclusion Criteria

1. Infertility attributable to genetic factors or severely reduced ovarian reserve
2. Serum hormonal profile showing a reduced ovarian reserve (AMH <0.9 ng/ml)
3. Irregular menstrual cycles or amenorrhea
4. Congenital or acquired uterine malformation
5. A body mass index (BMI) <20 or >26 kg/m²

Study & Design

• Study Type: Interventional
• Study Design: Not specified